Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 5:04 AM
Ignite Modification Date: 2025-12-26 @ 4:07 AM
NCT ID: NCT04731818
Description: From the time of informed consent to last visit
Frequency Threshold: 0
Time Frame: AE event monitoring for this study will began at the time of informed consent (Visit 1) through the last (visit 10), on average 3 months. First Screening was conducted February 8, 2021, and last subject last visit was February, 24, 2022.
Study: NCT04731818
Study Brief: An Exploratory Study of ZB-06 as a Vaginal Contraceptive Film
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
ZB-06 All participants will receive a single ZB-06 film for intravaginal administration prior to intercourse. ZB-06: ZB-06 is a polyvinyl alcohol-based film containing 20 mg of human contraceptive antibody (HCA) for topical intravaginal administration. 0 None 0 8 1 8 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Hyperkalemia SYSTEMATIC_ASSESSMENT Renal and urinary disorders None View